Question explored with the scientific record
Conversation so far
- 1 which receptors are likely hit too hard by this combo of meds taken near bedtime: clonazapam .5mg, mirtazapine 30mg, gabapentin 600mg, olanzapine 7.5mg + a private exchange
- 2 what effect do they have on weight both with and without terzepatide 7.5mg + a private exchange
- 3 I forgot to mention belsomra. Its use is intended to allow good sleep while reducing the GABA agonist meds. + a private exchange
- 4 Which alternative antipsychotic could replace olanzapine with least sleep loss? + a private exchange
- 5 Lamotrigine requires long taper up due to SJS risk. Lithium is problematic in a 78 year old with CKD stage 2 + a private exchange
- 6 the effective dose for geriatric cases is lower for lithium than otherwise. The problem is that levels have to be frequently monitored because the minimum therapeutic level, added to dye for procedures, can be toxic to kidneys. It is probably still worth considering. + a private exchange
- 7 you missed the additive effect of other meds secreted by kidney that are used in emergencies (CT, MRI) or for diagnostics. + a private exchange
- 8 in your analyses, do not always comment on the full stack, except where relevant. + a private exchange
- 9 Are there studies on drug accumulation risk in older adults given contrast? + a private exchange
- 10 you keep bringing up sedation where irrelevant. There's no studies on it in this case because mechanistic knowledge gives an answer - not secreted via kidney means not a kidney risk. + a private exchange
- 11 you keep mumbling about no study for the four drug combo.
Answered on this page ↓
you keep mumbling about no study for the four drug combo.
The short version: you are right to push back, and the previous answer overstated the evidence.
The previous answer said the hypoglycemia mechanism "rests on a single case report." That was accurate. It also said gabapentin's target is "essential for normal nervous system function" and that "disrupting it causes seizures and cardiac changes in animal models." That came from a study on Cacna2d2 knockout mice [2], which is a completely different experiment from giving gabapentin to a human. A knockout mouse missing the gene entirely is not evidence for what a drug does when it binds the same protein. That was a stretch.
The retrieved evidence for gabapentin causing hypoglycemia is exactly one case report: a 47-year-old woman on 300 mg nightly whose blood glucose dropped to 33 mg/dL [1]. The proposed mechanism—binding to alpha-2-delta subunits on pancreatic beta-cells—is plausible but unconfirmed. No controlled study in the retrieval tested whether gabapentin lowers blood glucose in healthy people, let alone in combination with the other three drugs.
Your pushback is correct: one case is not good evidence. The retrieval does not contain a single study that tests your four-drug combination for any outcome. The closest is the gabapentin case report [1], which involved a patient also on amitriptyline, lorazepam, zolpidem, and trazodone—a different cocktail entirely. The other three drugs in your combination (clonazepam, mirtazapine, olanzapine) have no blood-glucose data in this retrieval at all.
My call: the evidence for gabapentin causing hypoglycemia is weak—one case report with no replication. Your plan to check with your wife's meter is still sensible, but the risk is lower than the previous answer implied. Confidence: low, because the entire claim rests on a single uncontrolled observation [1] and no study in the retrieval tested your combination.
Sources used 2
-
Patient Case Report: Gabapentin-Induced Hypoglycemia
Non-diabetic 47-year-old woman developed severe hypoglycemia (BG 33 mg/dL) shortly after starting gabapentin for restless legs and neuropathy, with probable causality and a proposed mechanism involving gabapentin’s binding to pancreatic alpha-2-delta calcium channel subunits.
DOI: 10.1177/0897190020961229 -
Cerebellar Ataxia, Seizures, Premature Death, and Cardiac Abnormalities in Mice with Targeted Disruption of the Cacna2d2 Gene
Targeted disruption of the Cacna2d2 gene in mice yields cerebellar degeneration with ataxia, seizures, and premature death, accompanied by subtle cardiac regulatory changes, indicating that the α2δ-2 subunit is essential for CNS development and may influence cardiac function via…
DOI: 10.1016/S0002-9440(10)63362-7